Published ahead of print on August 1, 2008, doi:10.1165/rcmb.2007-0348OC
© 2009 American Thoracic Society DOI: 10.1165/rcmb.2007-0348OC Thy1 Up-Regulates FasL Expression in Lung Myofibroblasts via Src Family Kinases1 Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, Hadassah–Hebrew University Medical Center, Jerusalem, Israel; and 2 Department of Pathology, Boston University School of Medicine, Boston, Massachusetts Correspondence and requests for reprints should be addressed to Raphael Breuer, M.D., Head, Institute for Pulmonary Medicine, Hadassah–Hebrew University Medical Center, POB 12000, Jerusalem, Israel 91120. E-mail: raffi{at}hadassah.org.il
We have previously demonstrated that myofibroblasts from lungs with bleomycin-induced fibrosis overexpress FasL molecules. Two subpopulations of fibroblasts, distinguished by their expression of Thy1 molecules, have been shown in the lungs of both mice and humans. Thy1-mediated FasL induction has been reported in T cells through the use of anti-Thy1 (G7). We therefore sought to determine whether FasL expression in lung myofibroblasts is associated with and/or dependent on Thy1 expression, and to examine the underlying mechanism of regulation. We show that myofibroblast Thy1 expression is associated with increased FasL expression. Moreover, we directly show that Thy1 activation induces FasL up-regulation. Initially, Thy1 activation causes translocation of FasL to the membrane surface, and later induces de novo synthesis of FasL at the mRNA and protein levels. In contrast to Thy1 activation, TNF-
Key Words: FasL myofibroblast Src Thy-1
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||